| 25-Apr-06 (Click on the study number for summary details of the protocol.) |
| Array No. |
Disease Site |
Tot. Cases |
RTOG Study# |
Study Name |
| 01 Pilot |
Prostate |
50 |
8531 |
ZOLADEX ADJUVANT TO RT FOR NODE POSITIVE PROSTATE CA |
| 8610 |
ZOLADEX & FLUTAMIDE USED AS CYTOREDUCTIVE AGENTS - PROSTATE |
| Brain |
50 |
7401 |
MALIGNANT GLIOMAS |
| 7918 |
MISONIDAZOLE GLIOMA |
| 7903 |
MISONIDAZOLE AND NEUTRONS- MALIGNANT GLIOMA |
| 7611 |
NEUTRON GLIOMA |
| 8302 |
RANDOMIZED PHASE II HYPERFRACTIONATION - GLIOMA |
| 8007 |
NEUTRON ASTROCYTOMA + GLIOBLASTOM |
| 8201 |
TREATMENT OF GLIOBLASTOMA HYPERFRACTIONATION |
| H & N |
50 |
9501 |
HEAD & NECK: RT VS RT PLUS CHEMO |
| |
| 02 |
Prostate |
50 |
8610 |
ZOLADEX & FLUTAMIDE USED AS CYTOREDUCTIVE AGENTS - PROSTATE |
| |
| 04 |
Bladder |
74* |
8802 |
NEOADJUVANT COMBINED MODALITY PROGRAM WITH ORGAN PRESERVATION FOR BLADDER CA |
| 8903 |
MCV CHEMO AND RT FOR BLADDER PRESERVATION |
| 9506 |
BLADDER:PRESERVATION/CYSTECTOMY |
| 9706 |
BLADDER:CHEMO/RT FOR OPERABLE PATIENTS |
| |
| 05 |
H & N (4 block array) |
259 |
9003 |
HEAD & NECK: 4 ARM COMPARISON OF FX SCHEDULES |
| |
| 06 |
H & N (1 block array) |
179 |
9003 |
HEAD & NECK: 4 ARM COMPARISON OF FX SCHEDULES |
| |
| 07 |
Brain |
20 |
7401 |
MALIGNANT GLIOMAS |
| |
| 08 |
Brain |
156 |
7401 |
MALIGNANT GLIOMAS |
| 7918 |
MISONIDAZOLE GLIOMA |
| 8302 |
RANDOMIZED PHASE II HYPERFRACTIONATION - GLIOMA |
| 8409 |
RT AND AZQ CHEMO FOR MALIGNANT ASTROCYTOMA |
| 9006 |
GLIOMA:PHASE III HFX RT & BCNU VS CONVENTIONAL RT &BCNU |
| 9305 |
BRAIN:BCNU & RT +/- RADIOSURGERY |
| 9602 |
GLIOMA: PACLITAXEL AND STANDARD RT |
| 9806 |
BRAIN RT + THALIDOMIDE |
| |
| 09 |
H & N |
160 |
9501 |
HEAD & NECK: RT VS RT PLUS CHEMO |
| |
| 10 |
Brain |
106 |
8302 |
RANDOMIZED PHASE II HYPERFRACTIONATION - GLIOMA |
| 7401 |
MALIGNANT GLIOMAS |
| 7903 |
MISONIDAZOLE AND NEUTRONS- MALIGNANT GLIOMA |
| 9006 |
GLIOMA:PHASE III HFX RT & BCNU VS CONVENTIONAL RT &BCNU |
| 9404 |
BRAIN:ASTROCYTOMA/RT AND BUdR |
| 7918 |
MISONIDAZOLE GLIOMA |
| 9305 |
BRAIN:BCNU & RT +/- RADIOSURGERY |
| 9806 |
BRAIN RT + THALIDOMIDE |
| |
| 11 |
Pancreas |
229 |
9704 |
PANCREAS:CHEMORADIATION +/- GEMCITABINE |
| |
| 12 |
Rectum |
38 |
0012 |
RECTUM:PREOPERATIVE COMBINED MODALITY CHEMORADIATION |
| |
| 13 |
Esophagus |
59** |
9405 |
ESOPHAGUS:CHEMO PLUS RT/LOW DOSE VS. HIGH DOSE |
| |
| 14 |
Cervix |
62 |
0128 |
CERVIX: RT AND CELEBREX/CISPLATIN |
| |
| 15 |
Endometrium |
22 |
9708 |
ENDOMETRIUM:POST OP RT WITH TAXOL/CISPLATIN |
| |
| 16 |
Endometrium |
19 |
9905 |
ENDOMETRIUM:ADJUVANT RT +/-CHEMO FOLLOWING TAH/BSO |
| |
| 17 |
Larynx |
45 |
9111 |
LARYNX:3 ARM STUDY FOR LARYNGEAL PRESERVATION |
| |
| 18 |
Vocal Cord |
105 |
9512 |
T2 VOCAL CORD: ONCE A DAY VS TWICE A DAY RT |
| |
| 19 |
Brain |
Incomplete |
0211 |
BRAIN: RT AND IRESSA (ZD1839) |
| |
| *52 RTOG cases; 12 Massachusetts General cases |
| **37 positive cases; 22 negative cases |
